PlainRecalls
FDA Drug Critical Class I Terminated

Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05

Reported: January 25, 2023 Initiated: November 29, 2022 #D-0131-2023

Product Description

Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05

Reason for Recall

Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial

Details

Recalling Firm
Accord Healthcare, Inc.
Units Affected
Unknown
Distribution
Nationwide within the United States
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05. Recalled by Accord Healthcare, Inc.. Units affected: Unknown.
Why was this product recalled?
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2023. Severity: Critical. Recall number: D-0131-2023.